Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Divestments (2017 - 2024)

Historic Divestments for Haemonetics (HAE) over the last 5 years, with Q1 2024 value amounting to $1.5 million.

  • Haemonetics' Divestments changed N/A to $1.5 million in Q1 2024 from the same period last year, while for Mar 2024 it was $1.5 million, marking a year-over-year decrease of 8590.49%. This contributed to the annual value of $43.3 million for FY2025, which is 278606.67% up from last year.
  • As of Q1 2024, Haemonetics' Divestments stood at $1.5 million.
  • Haemonetics' 5-year Divestments high stood at $45.0 million for Q3 2020, and its period low was -$391000.0 during Q4 2020.
  • Its 3-year average for Divestments is $14.2 million, with a median of $6.1 million in 2022.
  • The largest annual percentage gain for Haemonetics' Divestments in the last 5 years was 282173.91% (2022), contrasted with its biggest fall of 282173.91% (2022).
  • Haemonetics' Divestments (Quarter) stood at -$391000.0 in 2020, then surged by 2821.74% to $10.6 million in 2022, then crashed by 85.9% to $1.5 million in 2024.
  • Its last three reported values are $1.5 million in Q1 2024, $10.6 million for Q1 2022, and -$391000.0 during Q4 2020.